The ‘supply chain’ patient is sick: is there a cure for the Pharma Supply Chain? (part 2)
Posted 12th December 2011 in Articles | Register to comment
In his concluding article Hedley Rees looks at the cure for the ‘sick’ pharmaceutical supply chain.
Well, is there a treatment option? Yes, I would say there is; and the regulators certainly think so too, having been pressing the industry for nearly…
Read the full articlemHealth Monthly Mashup: Release 6.0 – The gamification of healthcare and what it means for mobile
Posted 9th December 2011 in Articles | Register to comment
Checking in to his last instalment of the series for 2011, Michael Spitz discusses how gamification has impacted on mobile health.
The rapid evolution of smartphones, app stores, and healthcare user behaviours has created an mHealth revolution, one so exponential in…
Read the full articleHIV / AIDS statistics in South Africa: and the possible implications for the tx and dx industries (part 2)
Posted 8th December 2011 in Articles, General, Therapeutic Area | 11 comments
Chris Jennings continues his article highlighting ways in which he believes HIV / AIDS incidence have been overestimated.
As described in Part I of this article, few people realize that the familiar HIV/AIDS global statistics are actually estimates. For example…
Read the full articleRare is different: rare disease patients and caregivers want pharma to participate
Posted 7th December 2011 in Articles, General | Register to comment
Continuing the Rare is different series Wendy White demonstrates through patient stories the intense interest that patients have in building relationships with pharma.
The constraints of time and training limit most physicians’ abilities to effectively diagnose and treat rare disorders. This leads to…
Read the full articleImproving diabetes outcomes, one patient at a time
Posted 6th December 2011 in Articles, General, Therapeutic Area | Register to comment
Andi Weiss discusses the barriers to successful diabetes management and what can be done to overcome them.
The WHO reports that 346 million people have diabetes worldwide. Underscoring the growing problem, experts anticipate that number…
Read the full articleThe ‘supply chain’ patient is sick: is there a cure for the Pharma Supply Chain? (part 1)
Posted 5th December 2011 in Articles, General | Register to comment
In the first of two parts, Hedley Rees looks at the problems with the pharmaceutical supply chain and questions whether they can be resolved.
The Pharmaceutical supply chain has never been in such turmoil and under such attack from governments and regulators globally. The evidence is…
Read the full articlePatient perspectives: Lisa Emrich
Posted 2nd December 2011 in Articles, Interviews, Therapeutic Area | Register to comment
Continuing our conversations with highly visible epatients, pharmaphorum spoke to Lisa Emrich about her experience of rheumatoid arthritis, multiple sclerosis and pharma.
The work that epatient Lisa Emrich does in blogging about her experience helps not one, but two separate groups of individuals as she has been diagnosed with…
Read the full articleHIV / AIDS statistics in South Africa: and the possible implications for the tx and dx industries (part 1)
Posted 1st December 2011 in Articles, Therapeutic Area | 4 comments
In the first of his two-part article Chris Jennings identifies the false assumptions in HIV / AIDS incidence estimates that may have lead to a gross overestimation of the disease.
The situation with the African HIV/AIDS epidemic is analogous to that of the global finance crisis. Thousands of diligent people are…
Read the full articleEditor’s voice – November 2011
Posted 30th November 2011 in Articles, General | Register to comment
Rebecca Aris gives an overview of pharmaphorum’s November highlights.
So what’s so great about November? Well, it’s the month marked by Thanksgiving and Guy Fawkes Night, the month in which the…
Read the full articleThe changing role of key stakeholders in pharmaceutical value chain
Posted 30th November 2011 in Articles, General | Register to comment
The role of key stakeholders in pharmaceutical value chain has been in a state of transformation over the last decade. Dinar Kale explores.
The pharmaceutical value chain model depicted in Figure 1 covers a full range of activities that are required to bring a product from…
Read the full article